To view this email as a web page, click here.

 
Medicine no longer apolitical
Physicians writing in the Journal of the American Academy of Dermatology say that physicians should counter the proliferation of fake news on climate change.
 
Combination therapy improves survival in melanoma
The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.
ADVERTISEMENT
 
ASCO presentation questions survival differentiation between IIIA and IIIB
Researchers reporting at ASCO in June say the eighth edition AJCC melanoma staging systems differentiates melanoma survival slightly worse than the seventh edition.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.